This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This $1,480,186 Project Grant award from the Defense Health Agency supports research by Northeast Ohio Medical University (Neomed) to model cognitive dysfunction in Parkinson's disease and the impact of exercise. The research is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research, including solutions for the battlefield. As the sole awardee, Neomed...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $810,032 to Michigan State University to conduct research on neurobiological mechanisms to alleviate comorbid pain and obesity. The research will take place at Michigan State University's campus in East Lansing, Michigan and is expected to be completed by August 31, 2027. No details were provided on any sub-award recipients or services delivered under the grant.
This Project Grant award of $731,980.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The award will fund a research project titled "A DATA-DRIVEN APPROACH TO INDIVIDUALIZED CONCUSSION RISK PREDICTION IN U.S. SERVICE ACADEMY CADETS AND MIDSHIPMEN" from August 1, 2024 to July 31, 2027. The project aims to develop an individualized concussion risk prediction model for...
The Michigan State University was awarded a $704,249 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2021 to June 2024 to uncover mechanisms underlying cognitive changes and sleep in neurofibromatosis type 1 (NF1). The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
This Project Grant award of $2,037,497.00 from the Defense Health Agency was made to Michigan State University on September 30, 2023. The purpose of the grant is to transform behavioral health care to improve the quality of life for individuals with childhood-onset lupus. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public. As...
The Defense Health Agency awarded a $553,588 Project Grant to Michigan State University on September 1, 2023 to conduct research on "NEUROBIOLOGICAL MECHANISMS TO ALLEVIATE COMORBID PAIN AND OBESITY." This Project Grant is funded through the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As the prime awardee, Michigan State University...
The Defense Health Agency awarded a $2.4 million Project Grant to Rutgers, The State University of New Jersey for the role of NADPH oxidase1 (NOX1) in the colon in rotenone-induced alpha-synuclein pathology propagation along the gut-brain axis. The grant was awarded on July 1, 2022 under the Military Medical Research and Development program (CFDA 12.420) to investigate medical solutions for the battlefield and transform health care through innovative biomedical research. Specifically, Rutgers...
The Defense Health Agency awarded a $250,000 Project Grant to Rutgers, The State University of New Jersey to conduct research titled "BOOSTING MYELINATION USING VISUAL FLICKER IN THE ACUTE CUPRIZONE INTOXICATION MODEL". The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate medical solutions for the battlefield through basic, applied, and advanced biomedical research. The project is scheduled to be completed...